JW Pharmaceutical Corporation (KRX:001060)

Market Cap	511.41B
Revenue (ttm)	742.85B
Net Income (ttm)	50.08B
Shares Out	22.89M
EPS (ttm)	2,156.98
PE Ratio	10.32
Forward PE	n/a
Dividend	450.00 (2.02%)
Ex-Dividend Date	Dec 27, 2024

Volume	18,094
Average Volume	38,459
Open	21,650
Previous Close	21,400
Day's Range	21,450 - 21,650
52-Week Range	19,600 - 31,650
Beta	1.06
RSI	54.21
Earnings Date	Aug 14, 2025

About JW Pharmaceutical

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is base...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 1,068
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 001060

Financial Performance

In 2024, JW Pharmaceutical's revenue was 719.38 billion, a decrease of -3.89% compared to the previous year's 748.53 billion. Earnings were 60.78 billion, an increase of 64.24%.